Efficacy and Safety of Ulotaront in the Treatment of Schizophrenia: Results of Two 6-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

被引：0
|
作者：
Kane, John [1 ]
Dworak, Heather [1 ]
Koblan, Kenneth [1 ]
Szegedi, Armin [1 ]
Goldman, Robert [1 ]
Li, Yan [1 ]
Fitzgerald, Alison [1 ]
Loebel, Antony [1 ]
Marder, Stephen [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Teaneck, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Schizophrenia (SCZ); TAAR1; Phase III Trial; Clinical Trial; Ulotaront;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P495
引用
收藏
页码：351 / 351
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Correll, Christoph U.
    Skuban, Aleksandar
    Ouyang, John
    Hobart, Mary
    Pfister, Stephanie
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    Sanchez, Raymond
    Eriksson, Hans
    AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (09): : 870 - 880
  • [2] A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia
    Haas, Magali
    Unis, Alan S.
    Armenteros, Jorge
    Copenhaver, Margaret D.
    Quiroz, Jorge A.
    Kushner, Stuart F.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 611 - 621
  • [3] Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia in Japan: A 6-week, randomized, double-blind, placebo-controlled study
    Ishigooka, Jun
    Iwashita, Shuichi
    Tadori, Yoshihiro
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (09) : 692 - 700
  • [4] Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Nosaka, Tadashi
    Higuchi, Teruhiko
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (07) : 227 - 235
  • [5] Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Nosaka, Tadashi
    Higuchi, Teruhiko
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, : 227 - 235
  • [6] Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial
    Findling, Robert L.
    McKenna, Kathleen
    Earley, Willie R.
    Stankowski, Jill
    Pathak, Sanjeev
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (05) : 327 - 342
  • [7] LURASIDONE IN THE TREATMENT OF ACUTE SCHIZOPHRENIA: RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED, 6-WEEK, PEARL 3 TRIAL
    Loebel, Antony
    Cucchiaro, Josephine
    Sarma, K.
    Hsu, J.
    Kalali, A. H.
    Potkin, S. G.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 313 - 313
  • [8] Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study
    Iwata, Nakao
    Ishigooka, Jun
    Kim, Won-Hyoung
    Yoon, Bo-Hyun
    Lin, Shih-Ku
    Sulaiman, Ahmad Hatim
    Cosca, Rowena
    Wang, Lina
    Suchkov, Yury
    Agarkov, Alexey
    Watabe, Kei
    Matsui, Tomohito
    Sato, Takayuki
    Inoue, Yoshifumi
    Higuchi, Teruhiko
    Correll, Christoph U.
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2020, 215 : 408 - 415
  • [9] Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies
    Calisti, Fabrizio
    Cattaneo, Agnese
    Calabrese, Mariangela
    Mao, Yongcai
    Tocco, Michael
    Pikalov, Andrei
    Goldman, Robert
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2022, 37 (05) : 215 - 222
  • [10] Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Kryzhanovskaya, Ludmila
    Schulz, S. Charles
    McDougle, Christopher
    Frazier, Jean
    Dittmann, Ralf
    Robertson-Plouch, Carol
    Bauer, Theresa
    Xu, Wen
    Wang, Wei
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (01): : 60 - 70
12345